Prevalence of Depression Among Jordanian University Students During COVID-19 Pandemic-Reference-Cited by-同舟云学术

Prevalence of Depression Among Jordanian University Students During COVID-19 Pandemic

Published:2023-06-30 Issue:2 Volume:16 Page:785-790
ISSN:2456-2610
Container-title:Biomedical and Pharmacology Journal
language:en
Short-container-title:Biomed. Pharmacol. J.

Author:

Khwaldeh Alia¹^ORCID,Shoiab Aiman²^ORCID,Alsarhan Ali²^ORCID,Gardouh Ahmed³^ORCID,Alsheikh Ayman⁴^ORCID,Ababneh Sokiyna¹^ORCID,Alqaraleh Moath⁵^ORCID,Bdeir Roba

Affiliation:

1. 1Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Jadara University, Irbid

2. 2Department of pharmaceutical sciences, Faculty of Pharmacy, Jadara University, 21110 Irbid, Jordan.

3. 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522, Egypt

4. 4Faculty of Allied Medical Sciences, Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, Zarqa University, Zarqa, Jordan, 2000 Zarqa 13110,

5. 5Pharmacological and Diagnostic Research Center (PDRC), Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.

Abstract

Objective: The global COVID-19 pandemic has a significant impact on individuals, physical and mental health. This study aims to investigate the relationship between the COVID-19 pandemic and depression as a mental health problem among students of Jadara University. Methods: a cross-sectional study among Jadara University students by survey forms was conducted between 6 -12 of May 2020. The CES-D scale was used to assess depression. Result: Out of 200 participants, 45% were classified as high risk for depression and 55% as low risk for depression. Our resulting study revealed that the academic year and the professional status of the student had a significant relationship with depression. Conclusion: COVID-19 pandemic gives insight into the importance of universities and states natural resources to respond to mental health problems among the most vulnerable.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

Reference28 articles.

1. 1. who. Weekly epidemiological update on COVID-19—27 April 2021. WHO Geneva, Switzerland; 2021.

2. 2. Alsarhan A, Shoiab A, Gardouh A, Khwaldeh A, Alqaraleh M. Obesity risk throughout collective quarantine for the COVID-19. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2022;29(3):280-3.

3. 3. Choi EPH, Hui BPH, Wan EYFJIjoer, health p. Depression and anxiety in Hong Kong during COVID-19. 2020;17(10):3740.

4. 4. JT. Kingdom’s first confirmed coronavirus case ‘free of the virus’ — Health Ministry: THE JORDAN TIMES; 2020 [Available from: https://www.jordantimes.com/news/local/kingdoms-first-confirmed-coronavirus-case-%E2%80%98free-virus%E2%80%99-%E2%80%94-health-ministry.

5. 5. Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili S-M, Bahreini E. A comprehensive review of COVID-19 characteristics. Biological procedures online. 2020;22(1):1-10.